Nykredit A S Buys New Stake in Mettler-Toledo International, Inc. $MTD

Nykredit A S purchased a new position in Mettler-Toledo International, Inc. (NYSE:MTD) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 5,765 shares of the medical instruments supplier’s stock, valued at approximately $7,365,000.

Other institutional investors have also bought and sold shares of the company. B. Metzler seel. Sohn & Co. AG grew its stake in shares of Mettler-Toledo International by 1.0% in the 2nd quarter. B. Metzler seel. Sohn & Co. AG now owns 2,096 shares of the medical instruments supplier’s stock worth $2,678,000 after buying an additional 20 shares in the last quarter. Rehmann Capital Advisory Group raised its position in shares of Mettler-Toledo International by 12.0% during the 2nd quarter. Rehmann Capital Advisory Group now owns 205 shares of the medical instruments supplier’s stock valued at $262,000 after buying an additional 22 shares in the last quarter. Railway Pension Investments Ltd lifted its holdings in shares of Mettler-Toledo International by 327.2% in the 2nd quarter. Railway Pension Investments Ltd now owns 10,850 shares of the medical instruments supplier’s stock valued at $13,861,000 after acquiring an additional 8,310 shares during the last quarter. Quantitative Investment Management LLC bought a new position in shares of Mettler-Toledo International in the 2nd quarter valued at about $3,012,000. Finally, Benjamin Edwards Inc. grew its position in Mettler-Toledo International by 10.8% in the second quarter. Benjamin Edwards Inc. now owns 225 shares of the medical instruments supplier’s stock worth $287,000 after acquiring an additional 22 shares in the last quarter. Institutional investors own 95.07% of the company’s stock.

Insider Transactions at Mettler-Toledo International

In related news, Director Thomas P. Salice sold 417 shares of the stock in a transaction on Wednesday, August 5th. The stock was sold at an average price of $1,440.41, for a total value of $600,650.97. Following the completion of the transaction, the director directly owned 292 shares of the company’s stock, valued at approximately $420,599.72. This represents a 58.82% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Gerry Keller sold 240 shares of the firm’s stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $1,427.14, for a total transaction of $342,513.60. Following the completion of the transaction, the insider directly owned 259 shares in the company, valued at approximately $369,629.26. This represents a 48.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 4,254 shares of company stock worth $6,092,712. 0.71% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Rothschild & Co Redburn initiated coverage on shares of Mettler-Toledo International in a research report on Wednesday. They set a “sell” rating and a $1,200.00 price objective on the stock. Morgan Stanley upped their price target on shares of Mettler-Toledo International from $1,275.00 to $1,450.00 and gave the company an “equal weight” rating in a report on Tuesday, August 4th. Robert W. Baird reduced their price objective on Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating for the company in a research note on Monday, May 11th. Stifel Nicolaus upped their target price on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research note on Monday, August 3rd. Finally, Barclays raised their target price on Mettler-Toledo International from $1,300.00 to $1,575.00 and gave the stock an “overweight” rating in a report on Monday, August 3rd. Six research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $1,445.31.

Mettler-Toledo International Stock Down 0.8%

Shares of NYSE MTD opened at $1,344.87 on Friday. The firm has a market cap of $26.95 billion, a price-to-earnings ratio of 30.27, a price-to-earnings-growth ratio of 2.77 and a beta of 1.22. The company’s 50-day simple moving average is $1,361.63 and its 200-day simple moving average is $1,274.73. The company has a quick ratio of 0.78, a current ratio of 1.12 and a debt-to-equity ratio of 159.45. Mettler-Toledo International, Inc. has a 52-week low of $1,023.05 and a 52-week high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Friday, July 31st. The medical instruments supplier reported $11.46 earnings per share for the quarter, topping the consensus estimate of $10.78 by $0.68. Mettler-Toledo International had a net margin of 21.91% and a negative return on equity of 1,212.14%. The firm had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same quarter in the prior year, the firm earned $10.09 EPS. The company’s revenue for the quarter was up 4.5% on a year-over-year basis. Equities analysts predict that Mettler-Toledo International, Inc. will post 47.35 EPS for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.